Free Trial
→ Trump set to Boost Social Security Checks by 400%? (From InvestorPlace) (Ad) Buy BTX Stock  Free BTX Stock Alerts

Brooklyn ImmunoTherapeutics (BTX) SEC Filings & 10K Form

Brooklyn ImmunoTherapeutics logo
$7.14 0.00 (0.00%)
As of 06/20/2025 03:58 PM Eastern

Recent Brooklyn ImmunoTherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
06/19/2025
11:15 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
06/11/2025
7:34 PM		Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
7:39 PM		Cherington Charles (Filed by)
Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
06/11/2025
3:30 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/11/2025
3:35 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2025
8:13 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
05/15/2025
3:42 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Konar Shameek (Filed by)
Form SCHEDULE 13G
05/14/2025
7:39 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
1:14 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
10:48 AM		Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4/A
04/29/2025
11:15 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
04/16/2025
3:30 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/14/2025
4:05 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
04/04/2025
9:54 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
9:55 AM		Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
04/03/2025
4:17 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
04/03/2025
7:55 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
6:30 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:20 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
4:55 PM		Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
02/14/2025
8:30 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/17/2024
11:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/05/2024
11:42 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
A grave, grave error. (Ad)

President Donald Trump made headlines last month with a staggering claim. He stated that since taking office, more than $12 trillion in private investments into America have been “practically committed” on his watch. "Nobody's ever seen numbers like we have," he said, crediting his agenda of tariffs, tax cuts, and deregulation with making the difference. If true, the figure would indeed be astonishing – potentially tripling the roughly $4 trillion in gross private investment the US reported all of last year.

That means that you could still get in early on the biggest technological shift in history. But onl
10/29/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
09/27/2024
3:47 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
09/27/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
3:32 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

SEC Filings Tools

This page (NYSE:BTX) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
A grave, grave error.
It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...
Porter & Company | Sponsored
Most Bitcoin holders have no idea this exists
Here’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...
Brownstone Research | Sponsored
Why Is President Trump Fast-Tracking These Companies?
Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...
InvestorPlace | Sponsored
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored